February 2021, Volume 71, Issue 2


Coexisting systemic lupus erythematosus and suspected hyperimmunoglobulin E syndrome: A case report

Authors: Ricky Tjahjadi  ( Department of Clinical Pathology, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia. )
Yusra  ( Department of Clinical Pathology, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia. )


Hyperimmunoglobulin E syndrome (HIES) is a rare multisystem syndrome that affects musculoskeletal system, connective tissue, and immune system. Immune dysregulation in hyperimmunoglobulin E syndrome often accompanied by autoimmune diseases, such as systemic lupus erythematosus. While the role of IgG autoantibody is well known in the pathogenesis of systemic lupus erythematosus, other subtypes of autoantibodies, IgE in particular, are now known to be involved in autoimmune process. A female with known elevated IgE was diagnosed with adult onset HIES. Atypical chest pain and otherwise normal cardiac imaging studies prompted her for further lab testings. Positive antinuclear antibody immunofluorescence test and elevated anti ds-DNA led to SLE diagnosis. Lack of characteristic clinical manifestations complicates establishing HIES while showing the extent to which IgE elevation could be related to SLE.

Keywords: IgE, Hyperimmunoglobulin E syndrome, Systematic lupus erythematosus.




Hyperimmunoglobulin E syndrome (HIES) mostly occurs sporadically, although it could be inherited in an autosomal dominant or recessive manner. HIES is characterized by a classic triad: high serum IgE level (>2000 IU/mL), recurrent staphylococcal abscesses, recurrent pneumatocoele pneumonia.1 Depending on the type of inheritance, other symptoms may occur. Autosomal dominant HIES manifests as recurring dermatitis, sinusitis and ear infections, cold abscess, mucosa and nail fungal infections, scoliosis, and osteoporosis. Autosomal recessive HIES is characterized by increased susceptibility to Mycobacteria and Salmonella infections, recurring pneumatocoele pneumonia, and central nervous disorders such as hemiplegia and cerebral haemorrhage. None of the symptoms correlate with IgE level since HIES patients have IgE levels ranging from hundreds to thousands IU/Ml.1,2 IgE isotype dominance results in immune dysregulation and manifests as eosinophilia, neutrophil chemotaxis dysfunction due to reduction in C3b complement receptors, decreased interferon gamma (IFN-g) level and autoimmune diseases, including systemic lupus erythematosus (SLE), idiopathic thrombocytopenia purpura (ITP), and haemolytic anaemia.3

Increased IgE level is a common finding in SLE, reflecting Th2 immune response. Although it is possible to find autoreactive or nonspecific IgE in SLE, both contribute to the pathogenesis of SLE. The increase of nonspecific IgE is related to SLE activity and its complications, while autoreactive IgE responds to autoantigens not targeted by IgG autoantibody, creating immune complexes, commonly in kidneys. To date, autoreactive IgE is known to target at least 7 autoantigens, some, APEX nuclease I, N-methylpurine DNA glycosylase, and CAP-Gly domain-containing linker protein family protein 4, are not targetted by autoreactive IgG. IgE autoantibody could be detected using ANA indirect immunofluorescence (ANA IIF), which typically observed as the fine-speckled pattern on Hep-2 cells substrate.4,5

Internalization of IgG-nuclear component complexes by FcγRIIA activates plasmacytoid dendritic cell (DC) by toll-like receptor (TLR) 7, TLR9, which then activates NFkB and IRF7, to secrete IFN-a and other inflammatory cytokines. IFN-a drives B cell activation, maturation, and proliferation to create more autoantibodies. Previously, such mechanism only applied to IgG isotype autoantibody, but recent findings prove that autoreactive IgE also stimulates plasmacytoid DC by FceRI to the same extent as autoreactive IgG.6


Case Report


A 38-year old female came to the allergy and immunology clinic of a tertiary health care centre in July 2018 with complaints of heartburn, chest pain, and shortness of breath, which were alleviated by rest. Angiography and echocardiography yielded normal results. She had a history of IgE level around 1,000 IU/mL and was diagnosed as HIES. The patient was treated with mycophenolic acid for 3 months, reducing IgE to 600 IU/mL. A complete blood count, urinalysis, blood chemistry, and allergy immunology tests were performed later.

Based on those results, the patient had a follow up ANA profile test which revealed strong antibody to native SS-A, nucleosomes, and weak Ro-52 as shown in Figure-1.

The patient had normocytic anaemia, thrombocytosis, and elevated liver transaminases. The immunologic profile showed increased IgE, homogenous pattern of ANA IIF, elevated anti-dsDNA, confirmed by strong autoreactivity toward SS-A and nucleosome. Laboratory assessment was positive for immunologic criteria to support SLE diagnosis.




HIES is a genetic disorder that occurs sporadically or by inheritance, but symptoms could commonly be observed since childhood or early adolescence. Serum IgE is useful in assisting the diagnosis of HIES, but the patient's IgE of 613 IU/mL could be due to another primary immunodeficiency, infection, allergy, or SLE.10 Individuals with SLE produce varying autoantibodies, but autoreactive IgE is mostly prevalent in patients with more than 1/160 IgG ANA, and ds-DNA is the most commonly targeted autoantigen.4,5

Anaemia of chronic inflammatory state is the most common type of anaemia caused by both SLE and HIES while excluding other causes such as autoimmune haemolysis which still needs further workup. Thrombocytosis was more likely caused by reaction to inflammation. Positive blood by urine dipstick was inconsistent with otherwise normal urinalysis findings and renal function tests. Elevated liver transaminases were found in approximately 50% of SLE patients, but needed to be distinguished from other causes such as drug induced hepatitis or autoimmune hepatitis, which could be excluded by negative ribosomal protein antibody in the ANA profile test.6-8

Structural vascular defects were one of HIES manifestations; however, the exact prevalence rate was not known. However, defects such as tortuosity and focal aneurysm were ruled out since the patient had a normal angiography. Patient's angina like chest pain and heartburn were most likely associated to immunosuppressive therapies, including mycophenolic acid.9

The patient's homogenous ANA IIF and elevated anti-dsDNA supported immunologic criteria in diagnosing SLE, even though C3 and C4 were within normal ranges. ANA profile showed no reactivity to anti-dsDNA, but strong reaction was observed to nucleosome. Instead of protamine sulphate, both nucleosome and ds-DNA complex were used as substrates in anti-dsDNA-NcX ELISA method used in immunology laboratory of Cipto Mangunkusumo laboratory, explaining the discrepancy between anti-dsDNA and ANA profile test. The existence of autoreactive IgE had to be confirmed by IgE specific ANA fluorescence test.10




A 38-year old female with clinical info of hyper-IgE was found to have anaemia, thrombocythemia, elevated liver transaminases, homogenous ANA IIF with a titer of 1/1000, and strong ANA profile to SS-A, nucleosome, weak positive toward Ro-52, and negative anti ribosomal protein. She also had elevated anti-dsDNA and IgE levels. The diagnosis of SLE was supported by ANA, anti-dsDNA, and ANA profile. Diagnosis of HIES was not readily established due to lack of characteristic clinical manifestations and so needed further testing.


Acknowledgement: None to declare.

Disclaimer: None to declare.

Conflict of Interest: None to declare.

Funding Disclosure: The article received no grant.




1.      Hashemi H, Mohebbi M, Mehravaran S, Mazloumi M, Jahanbani-Ardakani H, Abtahi SH. Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities. J Res Med Sci 2017;22:53. doi: 10.4103/jrms.JRMS_1050_16.

2.      Murphy K, Weaver C. Failures of host defense mechanisms. Janeway's immunobiology, 9th ed. New York: Garland Science, 2017; pp 533-600.

3.      Yavuz H, Chee R. A review on the vascular features of the hyperimmunoglobulin E syndrome. Clin Exp Immunol 2010;159:238-44. doi: 10.1111/j.1365-2249.2009.04044.x.

4.      Atta AM, Sousa CP, Carvalho EM, Sousa-Atta ML. Immunoglobulin E and systemic lupus erythematosus. Braz J Med Biol Res 2004;37:1497-501. doi: 10.1590/s0100-879x2004001000008.

5.      Maurer M, Altrichter S, Schmetzer O, Scheffel J, Church MK, Metz M. Immunoglobulin E-Mediated Autoimmunity. Front Immunol 2018;9:689. doi: 10.3389/fimmu.2018.00689.

6.      Bayry J. Lupus pathogenesis: role of IgE autoantibodies. Cell Res 2016;26:271-2. doi: 10.1038/cr.2016.12.

7.      Kaw R, Gota C, Bennett A, Barnes D, Calabrese L. Lupus-related hepatitis: complication of lupus or autoimmune association? Case report and review of the literature. Dig Dis Sci 2006;51:813-8. doi: 10.1007/s10620-006-3212-1.

8.      Adiga A, Nugent K. Lupus Hepatitis and Autoimmune Hepatitis (Lupoid Hepatitis). Am J Med Sci 2017;353:329-35. doi: 10.1016/j.amjms.2016.10.014.

9.      Kumanovics A, LaPine TR. Autosomal dominant hyperimmunoglobulin E syndrome [Online] 2018 [Cited 2018 September 08]. Available from URL: https://www.uptodate.com

10.    Euroimmun. Anti-dsDNA-NcX ELISA (IgG) test instruction. [Online] 2013 [Cited 2018 September 08]. Available from URL: https://www.euroimmun.com/documents/Indications/Autoimmunity/Rheumatology/dsDNS/EA_1572_D_UK_A.pdf


Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees: